AI assistant
Opthea Ltd — Capital/Financing Update 2024
Jun 11, 2024
32698_rns_2024-06-11_2689a582-323f-4465-96cb-332197b0781e.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name OPTHEA LIMITED Announcement Type New announcement Date of this announcement 12/6/2024 The Proposed issue is: An accelerated offer A placement or other type of issue Total number of +securities proposed to be issued for an accelerated offer
| Maximum Number of | ||
|---|---|---|
| ASX +security code | +Security description | +securities to be issued |
| New class-code to be | Free attaching listed options expiring on 30 June 2026 | 181,095,255 |
| confirmed OPT |
ORDINARY FULLY PAID | 543,285,766 |
| Trading resumes on an ex-entitlement basis (ex date) | ||
| 14/6/2024 | ||
| +Record date | ||
| 14/6/2024 | ||
| Offer closing date for retail +security holders | ||
| 10/7/2024 | ||
| Issue date for retail +security holders |
17/7/2024
Total number of +securities proposed to be issued for a placement or other type of issue
| Maximum Number of | ||
|---|---|---|
| ASX +security code | +Security description | +securities to be issued |
| New class-code to be | Free attached listed options expiring on 30 June 2026 | 8,333,333 |
| confirmed | ||
| OPT | ORDINARY FULLY PAID | 25,000,000 |
Proposed +issue date
21/6/2024
Refer to next page for full details of the announcement
Appendix 3B - Proposed issue of securities
1 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of +Entity
OPTHEA LIMITED
We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.
If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).
1.2 Registered Number Type
ABN
Registration Number
32006340567
1.3 ASX issuer code
OPT
1.4 The announcement is
New announcement
1.5 Date of this announcement
12/6/2024
1.6 The Proposed issue is:
An accelerated offer A placement or other type of issue
1.6b The proposed accelerated offer is
Accelerated non-renounceable entitlement offer (commonly known as a JUMBO or ANREO)
Appendix 3B - Proposed issue of securities
2 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 3 - Details of proposed entitlement offer issue
Part 3A - Conditions
3A.1 Do any external approvals need to be obtained or other conditions satisfied before the entitlement offer can proceed on an unconditional basis? No
Part 3B - Offer details
+Class or classes of +securities that will participate in the proposed issue and +class or classes of +securities proposed to be issued
ASX +security code and description
OPT : ORDINARY FULLY PAID
Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Existing class
Will the proposed issue of this If the entity has quoted company +security include an offer of options, do the terms entitle option attaching +securities? holders to participate on exercise? Yes No
Details of +securities proposed to be issued
ASX +security code and description
OPT : ORDINARY FULLY PAID
ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them)
ISIN Code for the entitlement or right to participate in the offer (if Issuer is foreign company and +securities do not have +CDIs issued over them)
Offer ratio (ratio to existing holdings at which the proposed +securities will be issued) Has the offer ratio been determined? Yes
The quantity of additional +securities For a given quantity of +securities to be issued held 100 122 What will be done with fractional Maximum number of +securities entitlements? proposed to be issued (subject to
Appendix 3B - Proposed issue of securities
3 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
rounding)
Fractions rounded down to the nearest 543,285,766 whole number or fractions disregarded
Offer price details for retail security holders
Has the offer price for the retail offer been determined?
Yes
In what currency will the offer be What is the offer price per +security made? for the retail offer? AUD - Australian Dollar AUD 0.40000
Offer price details for institutional security holders
Has the offer price for the institutional offer been determined? Yes
In what currency will the offer be What is the offer price per +security made? for the institutional offer? AUD 0.40000
AUD - Australian Dollar
Oversubscription & Scale back details
Will individual +security holders be permitted to apply for more than their entitlement (i.e. to over-subscribe)?
Yes
Describe the limits on over-subscription
Eligible retail shareholders who take-up all of their entitlement to new shares under the Retail Entitlement Offer may also apply for additional new shares under the top up facility, up to an additional 25% of the shareholder's entitlement
Will a scale back be applied if the offer is over-subscribed? Yes
Describe the scale back arrangements
If the number of additional New Shares for which applications are received under the Top-Up Facility exceeds the number of New Shares available for allocation under the Top-Up Facility, the Opthea may apply for any scale-back in its discretion, which may include having regard to the pro rate Entitlement of Eligible Retail Shareholders who apply for additional New Shares
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Attaching +Security
Is the proposed attaching security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional +securities in a class that is already quoted or recorded by ASX)? New class
Attaching +Security - New class (+securities in a class that is not yet quoted or recorded by ASX)
Details of attaching +securities proposed to be issued
Appendix 3B - Proposed issue of securities
4 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them)
ISIN Code for the entitlement or right to participate in the offer (if Issuer is foreign company and +securities do not have +CDIs issued over them)
| Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1? Will the entity be seeking quotation of the 'new' class of +securities on ASX? ASX +security code New class-code to be confirmed +Security description Free attaching listed options expiring on 30 June 2026 Yes Yes |
Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1? Will the entity be seeking quotation of the 'new' class of +securities on ASX? ASX +security code New class-code to be confirmed +Security description Free attaching listed options expiring on 30 June 2026 Yes Yes |
|---|---|
| New class-code to be confirmed | Free attaching listed options expiring on 30 June 2026 |
+Security type
Options
Offer ratio (ratio of attaching securities at which the new +securities will be issued)
| Offer ratio (ratio of attaching securities at which the new | +securities will be issued) |
|---|---|
| Has the offer ratio been determined? | |
| Yes | |
| The quantity of attaching +securities to be issued | For a given quantity of the new +securities issued |
| 1 | 3 |
| What will be done with fractional entitlements? | Maximum number of +securities proposed to be issued |
| Fractions rounded down to the nearest whole number or | (subject to rounding) |
| fractions disregarded | 181,095,255 |
| Offer price details for retail security holders | |
| Has the offer price for the retail offer been determined? | |
| Yes | |
| In what currency will the offer be made? | What is the offer price per +security for the retail offer? |
| AUD 0.00000 | |
| AUD - Australian Dollar |
Offer price details for institutional security holders
| Has the offer price for the institutional offer been determined? | Has the offer price for the institutional offer been determined? |
|---|---|
| Yes | |
| In what currency will the offer be made? | What is the offer price per +security for the institutional |
| offer? | |
| AUD - Australian Dollar | AUD 0.00000 |
Oversubscription & Scale back details
Will individual +security holders be permitted to apply for more than their entitlement (i.e. to over-subscribe)? Yes
Describe the limits on over-subscription
Eligible retail shareholders who take-up all of their entitlement to new shares under the Retail Entitlement Offer may also apply for additional new shares under the top up facility, up to an additional 25% of the shareholder's entitlement
Will a scale back be applied if the offer is
Appendix 3B - Proposed issue of securities
5 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
over-subscribed? Yes Describe the scale back arrangements If the number of additional New Shares for which applications are received under the Top-Up Facility exceeds the number of New Shares available for allocation under the Top-Up Facility, the Opthea may apply for any scale-back in its discretion, which may include having regard to the pro rate Entitlement of Eligible Retail Shareholders who apply for additional New Shares Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Options details +Security currency AUD - Australian Dollar Exercise price Expiry date AUD 1.0000 30/6/2026 Details of the type of +security that will be issued if the option is exercised OPT : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised 181095255 Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. See section 6.7 of the prospectus lodged with ASX on 12 June 2024 for terms of Options
Part 3D - Timetable 3D.1a First day of trading halt 12/6/2024 3D.1b Announcement date of accelerated offer 12/6/2024 3D.2 Trading resumes on an ex-entitlement basis (ex date) 14/6/2024 3D.5 Date offer will be made to eligible institutional +security holders 12/6/2024 3D.6 Application closing date for institutional +security holders 13/6/2024
Appendix 3B - Proposed issue of securities
6 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
3D.8 Announcement of results of institutional offer (The announcement should be made before the resumption of trading following the trading halt) 14/6/2024 3D.9 +Record date 14/6/2024 3D.10a Settlement date of new +securities issued under institutional entitlement offer 21/6/2024 3D.10b +Issue date for institutional +security holders 21/6/2024 3D.10c Normal trading of new +securities issued under institutional entitlement offer 21/6/2024
3D.11 Date on which offer documents will be sent to retail +security holders entitled to participate in the +pro rata issue
19/6/2024
3D.12 Offer closing date for retail +security holders
10/7/2024
3D.13 Last day to extend retail offer close date
5/7/2024
3D.19 +Issue date for retail +security holders and last day for entity to announce results of retail offer 17/7/2024
Part 3E - Fees and expenses
3E.1 Will there be a lead manager or broker to the proposed offer? Yes 3E.1a Who is the lead manager/broker? MST Financial Services Pty Ltd 3E.1b What fee, commission or other consideration is payable to them for acting as lead manager/broker? In respect of the entitlement offer, MST Financial will be paid a management fee of 2.25% of the total cash proceeds of the entitlement offer 3E.2 Is the proposed offer to be underwritten? Yes 3E.2a Who are the underwriter(s)? MST Financial Services Pty Ltd
Appendix 3B - Proposed issue of securities
7 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
3E.2b What is the extent of the underwriting (ie the amount or proportion of the offer that is underwritten)?
A full underwriting of the retail entitlement offer and a partial underwriting of the shortfall of the institutional entitlement offer up to $30million
3E.2c What fees, commissions or other consideration are payable to them for acting as underwriter(s)?
MST will be paid an underwriting fee of 3% on the total cash proceeds raised from the Entitlement Offer.
3E.2d Please provide a summary of the significant events that could lead to the underwriting being terminated
Please refer to the summary of the Underwriting Agreement section of the Investor Presentation and Prospectus announced to ASX on Wednesday, 12 June 2024.
3E.2e Is a party referred to in listing rule 10.11 underwriting or sub-underwriting the proposed offer? No
3E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? No
3E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer
Fees and costs incurred by OPT in connection with the entitlement offer include the lead manager fees, underwriting fees and sub-underwriting fees noted above, share registry fees, settlement fees and legal fees.
Part 3F - Further Information
3F.1 The purpose(s) for which the entity intends to use the cash raised by the proposed issue
To continue the clinical development of sozinibercept for the treatment of wet AMD, to progress the Phase 3 clinical program, chemistry manufacturing and controls activities, biologic filing application preparations and general corporate purposes
3F.2 Will holdings on different registers or subregisters be aggregated for the purposes of determining entitlements to the issue?
No
3F.3 Will the entity be changing its dividend/distribution policy if the proposed issue is successful? No 3F.4 Countries in which the entity has +security holders who will not be eligible to participate in the proposed issue
All countries other than Australia, New Zealand and certain institutional shareholders in the European Union, United Kingdom, United States, Israel, Singapore, South Africa and Hong Kong.
3F.5 Will the offer be made to eligible beneficiaries on whose behalf eligible nominees or custodians hold existing +securities Yes
3F.5a Please provide further details of the offer to eligible beneficiaries
Refer to section 2.18 of the Prospectus lodged with the ASX on June 12, 2024.
3F.6 URL on the entity's website where investors can download information about the proposed issue
- https://ir.opthea.com/asx filings
3F.7 Any other information the entity wishes to provide about the proposed issue
Refer to ASX announcement "Opthea Announces Placement and Partially Underwritten Entitlement Offer to raise up to A$227.3 million (US$150.0 million)" and Prospectus lodged on June 12, 2024.
3F.8 Will the offer of rights under the rights issue be made under a +disclosure document or product disclosure statement under Chapter 6D or Part 7.9 of the Corporations Act (as applicable)? Yes
3F.9 Any on-sale of the +securities proposed to be issued within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a +disclosure document or +PDS for the +securities proposed to be issued
Appendix 3B - Proposed issue of securities
8 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
==> picture [540 x 710] intentionally omitted <==
Appendix 3B - Proposed issue of securities
9 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 7 - Details of proposed placement or other issue
Part 7A - Conditions
7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis? No
Part 7B - Issue details
Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Existing class
Will the proposed issue of this +security include an offer of attaching +securities? Yes
Details of +securities proposed to be issued
ASX +security code and description
OPT : ORDINARY FULLY PAID
Number of +securities proposed to be issued
25,000,000
Offer price details
Are the +securities proposed to be issued being issued for a cash consideration? Yes
In what currency is the cash What is the issue price per consideration being paid? +security? AUD - Australian Dollar AUD 0.40000
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes
Attaching +Security
Is the proposed attaching security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional +securities in a class that is already quoted or recorded by ASX)? New class
Appendix 3B - Proposed issue of securities
10 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Attaching +Security - New class (+securities in a class that is not yet quoted or recorded by ASX)
Details of attaching +securities proposed to be issued
ISIN Code (if Issuer is a foreign company and +securities do not have +CDIs issued over them)
Have you received confirmation from ASX that the terms Will the entity be seeking quotation of the 'new' class of of the proposed +securities are appropriate and +securities on ASX? equitable under listing rule 6.1? Yes Yes ASX +security code +Security description New class-code to be confirmed Free attached listed options expiring on 30 June 2026 +Security type Options Number of +securities proposed to be issued 8,333,333 Offer price details Are the +securities proposed to be issued being issued for a cash consideration? No Please describe the consideration being provided for the +securities Free attaching listed options expiring on 30 June 2026 Please provide an estimate of the AUD equivalent of the consideration being provided for the +securities 0.00000001 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Options details +Security currency AUD - Australian Dollar Exercise price Expiry date AUD 1.0000 30/6/2026 Details of the type of +security that will be issued if the option is exercised OPT : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised 8333333 Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. - https://ir.opthea.com/asx filings
Appendix 3B - Proposed issue of securities
11 / 13
Appendix 3B - Proposed issue of securities
==> picture [21 x 22] intentionally omitted <==
Part 7C - Timetable
7C.1 Proposed +issue date
21/6/2024
Part 7D - Listing Rule requirements
7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? No
7D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? Yes
7D.1b ( i ) How many +securities are proposed to be issued without security holder approval using the entity's 15% placement capacity under listing rule 7.1?
25,000,000 Shares
8,333,333 Options
7D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No 7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No 7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules? No
7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No
Part 7E - Fees and expenses
7E.1 Will there be a lead manager or broker to the proposed issue? Yes
7E.1a Who is the lead manager/broker?
The lead manager to the placement is MST Financial Services Pty Ltd ( MST)
7E.1b What fee, commission or other consideration is payable to them for acting as lead manager/broker?
In respect of the placement MST financial Services will be paid a management fee of 2.25% of the placement amount and a selling fee of 3% of the placement amount.
7E.2 Is the proposed issue to be underwritten? No
7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue
Fees and costs incurred by OPT in connection with the placement include lead manager fees noted above, share registry fees, settlement fees and legal fees.
Appendix 3B - Proposed issue of securities
12 / 13
Appendix 3B - Proposed issue of securities
Part 7F - Further Information
==> picture [21 x 22] intentionally omitted <==
7F.01 The purpose(s) for which the entity is issuing the securities
To continue the clinical development of sozinibercept for the treatment of wet AMD, to progress the Phase 3 clinical program, chemistry manufacturing and controls activities, biologic filing application preparations and general corporate purposes
7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No
7F.2 Any other information the entity wishes to provide about the proposed issue
Fo further details of the placement please refer to the ASX announcement "Opthea Announces Placement and Partially Underwritten Entitlement Offer to raise up to A$227.3 million (US$150.0 million)", Investor Presentation and Prospectus released to ASX by the Company on Wednesday, June 12, 2024.
7F.3 Any on-sale of the +securities proposed to be issued within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)
Appendix 3B - Proposed issue of securities
13 / 13